nodes	percent_of_prediction	percent_of_DWPC	metapath
Nalbuphine—Naloxone—TLR4—melanoma	0.0157	0.614	CrCbGaD
Nalbuphine—Speech disorder—Carmustine—melanoma	0.00817	0.0208	CcSEcCtD
Nalbuphine—Speech disorder—Temozolomide—melanoma	0.00789	0.0201	CcSEcCtD
Nalbuphine—Wheezing—Bleomycin—melanoma	0.00782	0.0199	CcSEcCtD
Nalbuphine—Injection site reaction—Carmustine—melanoma	0.00698	0.0177	CcSEcCtD
Nalbuphine—Redness—Docetaxel—melanoma	0.00669	0.017	CcSEcCtD
Nalbuphine—Erythema—Vemurafenib—melanoma	0.00581	0.0148	CcSEcCtD
Nalbuphine—Swelling—Carmustine—melanoma	0.00578	0.0147	CcSEcCtD
Nalbuphine—Dysgeusia—Vemurafenib—melanoma	0.00569	0.0144	CcSEcCtD
Nalbuphine—Bronchospasm—Bleomycin—melanoma	0.00497	0.0126	CcSEcCtD
Nalbuphine—Injection site reaction—Docetaxel—melanoma	0.00449	0.0114	CcSEcCtD
Nalbuphine—Hypotension—Vemurafenib—melanoma	0.00443	0.0113	CcSEcCtD
Nalbuphine—Sweating increased—Temozolomide—melanoma	0.00415	0.0105	CcSEcCtD
Nalbuphine—Hypoaesthesia—Bleomycin—melanoma	0.00402	0.0102	CcSEcCtD
Nalbuphine—Pulmonary oedema—Docetaxel—melanoma	0.00402	0.0102	CcSEcCtD
Nalbuphine—Pollakiuria—Temozolomide—melanoma	0.00393	0.01	CcSEcCtD
Nalbuphine—Depression—Carmustine—melanoma	0.00392	0.00996	CcSEcCtD
Nalbuphine—Depression—Temozolomide—melanoma	0.00379	0.00962	CcSEcCtD
Nalbuphine—Flushing—Bleomycin—melanoma	0.00375	0.00953	CcSEcCtD
Nalbuphine—Body temperature increased—Vemurafenib—melanoma	0.00375	0.00952	CcSEcCtD
Nalbuphine—Swelling—Docetaxel—melanoma	0.00371	0.00944	CcSEcCtD
Nalbuphine—Erythema—Bleomycin—melanoma	0.00352	0.00894	CcSEcCtD
Nalbuphine—Hypoaesthesia—Carmustine—melanoma	0.00351	0.00892	CcSEcCtD
Nalbuphine—Hallucination—Carmustine—melanoma	0.00351	0.00892	CcSEcCtD
Nalbuphine—Flushing—Dactinomycin—melanoma	0.0035	0.00889	CcSEcCtD
Nalbuphine—Hypersensitivity—Vemurafenib—melanoma	0.00349	0.00887	CcSEcCtD
Nalbuphine—Asthenia—Vemurafenib—melanoma	0.0034	0.00864	CcSEcCtD
Nalbuphine—Hypoaesthesia—Temozolomide—melanoma	0.00339	0.00862	CcSEcCtD
Nalbuphine—Hallucination—Temozolomide—melanoma	0.00339	0.00862	CcSEcCtD
Nalbuphine—Pruritus—Vemurafenib—melanoma	0.00335	0.00852	CcSEcCtD
Nalbuphine—Erythema—Dactinomycin—melanoma	0.00328	0.00834	CcSEcCtD
Nalbuphine—Flushing—Carmustine—melanoma	0.00327	0.00832	CcSEcCtD
Nalbuphine—Flushing—Temozolomide—melanoma	0.00316	0.00804	CcSEcCtD
Nalbuphine—Dizziness—Vemurafenib—melanoma	0.00313	0.00796	CcSEcCtD
Nalbuphine—Erythema—Carmustine—melanoma	0.00307	0.0078	CcSEcCtD
Nalbuphine—Vomiting—Vemurafenib—melanoma	0.00301	0.00766	CcSEcCtD
Nalbuphine—Rash—Vemurafenib—melanoma	0.00299	0.00759	CcSEcCtD
Nalbuphine—Dermatitis—Vemurafenib—melanoma	0.00299	0.00759	CcSEcCtD
Nalbuphine—Headache—Vemurafenib—melanoma	0.00297	0.00754	CcSEcCtD
Nalbuphine—Erythema—Temozolomide—melanoma	0.00297	0.00754	CcSEcCtD
Nalbuphine—Cramp muscle—Docetaxel—melanoma	0.00295	0.0075	CcSEcCtD
Nalbuphine—Dysgeusia—Temozolomide—melanoma	0.00291	0.00738	CcSEcCtD
Nalbuphine—Confusional state—Bleomycin—melanoma	0.00289	0.00736	CcSEcCtD
Nalbuphine—Vision blurred—Carmustine—melanoma	0.00289	0.00735	CcSEcCtD
Nalbuphine—Tremor—Carmustine—melanoma	0.00288	0.00731	CcSEcCtD
Nalbuphine—Oedema—Bleomycin—melanoma	0.00287	0.0073	CcSEcCtD
Nalbuphine—Agitation—Carmustine—melanoma	0.00282	0.00717	CcSEcCtD
Nalbuphine—Nausea—Vemurafenib—melanoma	0.00281	0.00715	CcSEcCtD
Nalbuphine—Vision blurred—Temozolomide—melanoma	0.0028	0.00711	CcSEcCtD
Nalbuphine—Bronchospasm—Docetaxel—melanoma	0.00279	0.00708	CcSEcCtD
Nalbuphine—Tremor—Temozolomide—melanoma	0.00278	0.00707	CcSEcCtD
Nalbuphine—Agitation—Temozolomide—melanoma	0.00273	0.00693	CcSEcCtD
Nalbuphine—Hypotension—Bleomycin—melanoma	0.00268	0.00682	CcSEcCtD
Nalbuphine—Oedema—Dactinomycin—melanoma	0.00268	0.0068	CcSEcCtD
Nalbuphine—Vertigo—Temozolomide—melanoma	0.00267	0.00678	CcSEcCtD
Nalbuphine—Convulsion—Carmustine—melanoma	0.00266	0.00676	CcSEcCtD
Nalbuphine—Hypertension—Carmustine—melanoma	0.00265	0.00674	CcSEcCtD
Nalbuphine—Anxiety—Carmustine—melanoma	0.00261	0.00662	CcSEcCtD
Nalbuphine—Paraesthesia—Bleomycin—melanoma	0.00258	0.00655	CcSEcCtD
Nalbuphine—Convulsion—Temozolomide—melanoma	0.00257	0.00653	CcSEcCtD
Nalbuphine—Hypertension—Temozolomide—melanoma	0.00256	0.00651	CcSEcCtD
Nalbuphine—Dyspnoea—Bleomycin—melanoma	0.00256	0.0065	CcSEcCtD
Nalbuphine—Naltrexone—ABCB1—melanoma	0.00256	0.1	CrCbGaD
Nalbuphine—Confusional state—Carmustine—melanoma	0.00253	0.00642	CcSEcCtD
Nalbuphine—Anxiety—Temozolomide—melanoma	0.00252	0.0064	CcSEcCtD
Nalbuphine—Oedema—Carmustine—melanoma	0.00251	0.00637	CcSEcCtD
Nalbuphine—Dry mouth—Temozolomide—melanoma	0.00247	0.00628	CcSEcCtD
Nalbuphine—Tachycardia—Carmustine—melanoma	0.00245	0.00622	CcSEcCtD
Nalbuphine—Confusional state—Temozolomide—melanoma	0.00244	0.00621	CcSEcCtD
Nalbuphine—Oedema—Temozolomide—melanoma	0.00242	0.00615	CcSEcCtD
Nalbuphine—Feeling abnormal—Bleomycin—melanoma	0.00237	0.00601	CcSEcCtD
Nalbuphine—Hypotension—Carmustine—melanoma	0.00234	0.00595	CcSEcCtD
Nalbuphine—Hyperhidrosis—Temozolomide—melanoma	0.00234	0.00595	CcSEcCtD
Nalbuphine—Urticaria—Bleomycin—melanoma	0.00228	0.0058	CcSEcCtD
Nalbuphine—Body temperature increased—Bleomycin—melanoma	0.00227	0.00577	CcSEcCtD
Nalbuphine—Hypoaesthesia—Docetaxel—melanoma	0.00226	0.00573	CcSEcCtD
Nalbuphine—Paraesthesia—Carmustine—melanoma	0.00225	0.00572	CcSEcCtD
Nalbuphine—Dyspnoea—Carmustine—melanoma	0.00223	0.00568	CcSEcCtD
Nalbuphine—Somnolence—Carmustine—melanoma	0.00223	0.00566	CcSEcCtD
Nalbuphine—Feeling abnormal—Dactinomycin—melanoma	0.00221	0.00561	CcSEcCtD
Nalbuphine—Gastrointestinal pain—Dactinomycin—melanoma	0.00219	0.00556	CcSEcCtD
Nalbuphine—Paraesthesia—Temozolomide—melanoma	0.00217	0.00553	CcSEcCtD
Nalbuphine—Dyspnoea—Temozolomide—melanoma	0.00216	0.00549	CcSEcCtD
Nalbuphine—Somnolence—Temozolomide—melanoma	0.00215	0.00547	CcSEcCtD
Nalbuphine—Dyspepsia—Temozolomide—melanoma	0.00213	0.00542	CcSEcCtD
Nalbuphine—Abdominal pain—Dactinomycin—melanoma	0.00212	0.00538	CcSEcCtD
Nalbuphine—Body temperature increased—Dactinomycin—melanoma	0.00212	0.00538	CcSEcCtD
Nalbuphine—Hypersensitivity—Bleomycin—melanoma	0.00212	0.00538	CcSEcCtD
Nalbuphine—Flushing—Docetaxel—melanoma	0.0021	0.00535	CcSEcCtD
Nalbuphine—Feeling abnormal—Carmustine—melanoma	0.00207	0.00525	CcSEcCtD
Nalbuphine—Asthenia—Bleomycin—melanoma	0.00206	0.00523	CcSEcCtD
Nalbuphine—Gastrointestinal pain—Carmustine—melanoma	0.00205	0.00521	CcSEcCtD
Nalbuphine—Pruritus—Bleomycin—melanoma	0.00203	0.00516	CcSEcCtD
Nalbuphine—Feeling abnormal—Temozolomide—melanoma	0.002	0.00507	CcSEcCtD
Nalbuphine—Abdominal pain—Carmustine—melanoma	0.00198	0.00503	CcSEcCtD
Nalbuphine—Body temperature increased—Carmustine—melanoma	0.00198	0.00503	CcSEcCtD
Nalbuphine—Gastrointestinal pain—Temozolomide—melanoma	0.00198	0.00503	CcSEcCtD
Nalbuphine—Erythema—Docetaxel—melanoma	0.00197	0.00501	CcSEcCtD
Nalbuphine—Hypersensitivity—Dactinomycin—melanoma	0.00197	0.00501	CcSEcCtD
Nalbuphine—Naloxone—ALB—melanoma	0.00196	0.0767	CrCbGaD
Nalbuphine—Dysgeusia—Docetaxel—melanoma	0.00193	0.00491	CcSEcCtD
Nalbuphine—Urticaria—Temozolomide—melanoma	0.00192	0.00489	CcSEcCtD
Nalbuphine—Asthenia—Dactinomycin—melanoma	0.00192	0.00488	CcSEcCtD
Nalbuphine—Abdominal pain—Temozolomide—melanoma	0.00191	0.00487	CcSEcCtD
Nalbuphine—Body temperature increased—Temozolomide—melanoma	0.00191	0.00487	CcSEcCtD
Nalbuphine—Muscle spasms—Docetaxel—melanoma	0.0019	0.00482	CcSEcCtD
Nalbuphine—Buprenorphine—ABCB1—melanoma	0.00188	0.0737	CrCbGaD
Nalbuphine—Naloxone—ABCB1—melanoma	0.00187	0.0732	CrCbGaD
Nalbuphine—Hypersensitivity—Carmustine—melanoma	0.00185	0.00469	CcSEcCtD
Nalbuphine—Vomiting—Bleomycin—melanoma	0.00183	0.00464	CcSEcCtD
Nalbuphine—Rash—Bleomycin—melanoma	0.00181	0.0046	CcSEcCtD
Nalbuphine—Dermatitis—Bleomycin—melanoma	0.00181	0.0046	CcSEcCtD
Nalbuphine—Asthenia—Carmustine—melanoma	0.0018	0.00457	CcSEcCtD
Nalbuphine—Hypersensitivity—Temozolomide—melanoma	0.00178	0.00453	CcSEcCtD
Nalbuphine—Syncope—Docetaxel—melanoma	0.00177	0.0045	CcSEcCtD
Nalbuphine—Asthenia—Temozolomide—melanoma	0.00174	0.00442	CcSEcCtD
Nalbuphine—Loss of consciousness—Docetaxel—melanoma	0.00173	0.00441	CcSEcCtD
Nalbuphine—Pruritus—Temozolomide—melanoma	0.00171	0.00435	CcSEcCtD
Nalbuphine—Convulsion—Docetaxel—melanoma	0.00171	0.00434	CcSEcCtD
Nalbuphine—Nausea—Bleomycin—melanoma	0.00171	0.00433	CcSEcCtD
Nalbuphine—Hypertension—Docetaxel—melanoma	0.0017	0.00433	CcSEcCtD
Nalbuphine—Vomiting—Dactinomycin—melanoma	0.0017	0.00433	CcSEcCtD
Nalbuphine—Rash—Dactinomycin—melanoma	0.00169	0.00429	CcSEcCtD
Nalbuphine—Dizziness—Carmustine—melanoma	0.00166	0.00421	CcSEcCtD
Nalbuphine—Dry mouth—Docetaxel—melanoma	0.00164	0.00418	CcSEcCtD
Nalbuphine—Confusional state—Docetaxel—melanoma	0.00162	0.00413	CcSEcCtD
Nalbuphine—Oedema—Docetaxel—melanoma	0.00161	0.00409	CcSEcCtD
Nalbuphine—Dizziness—Temozolomide—melanoma	0.0016	0.00407	CcSEcCtD
Nalbuphine—Vomiting—Carmustine—melanoma	0.00159	0.00405	CcSEcCtD
Nalbuphine—Nausea—Dactinomycin—melanoma	0.00159	0.00404	CcSEcCtD
Nalbuphine—Shock—Docetaxel—melanoma	0.00158	0.00403	CcSEcCtD
Nalbuphine—Rash—Carmustine—melanoma	0.00158	0.00402	CcSEcCtD
Nalbuphine—Dermatitis—Carmustine—melanoma	0.00158	0.00401	CcSEcCtD
Nalbuphine—Morphine—ABCB1—melanoma	0.00158	0.0618	CrCbGaD
Nalbuphine—Tachycardia—Docetaxel—melanoma	0.00157	0.00399	CcSEcCtD
Nalbuphine—Headache—Carmustine—melanoma	0.00157	0.00399	CcSEcCtD
Nalbuphine—Vomiting—Temozolomide—melanoma	0.00154	0.00391	CcSEcCtD
Nalbuphine—Rash—Temozolomide—melanoma	0.00153	0.00388	CcSEcCtD
Nalbuphine—Dermatitis—Temozolomide—melanoma	0.00153	0.00388	CcSEcCtD
Nalbuphine—Headache—Temozolomide—melanoma	0.00152	0.00386	CcSEcCtD
Nalbuphine—Hypotension—Docetaxel—melanoma	0.0015	0.00382	CcSEcCtD
Nalbuphine—Nausea—Carmustine—melanoma	0.00149	0.00378	CcSEcCtD
Nalbuphine—Paraesthesia—Docetaxel—melanoma	0.00145	0.00368	CcSEcCtD
Nalbuphine—Nausea—Temozolomide—melanoma	0.00144	0.00366	CcSEcCtD
Nalbuphine—Dyspnoea—Docetaxel—melanoma	0.00144	0.00365	CcSEcCtD
Nalbuphine—Somnolence—Docetaxel—melanoma	0.00143	0.00364	CcSEcCtD
Nalbuphine—Dyspepsia—Docetaxel—melanoma	0.00142	0.0036	CcSEcCtD
Nalbuphine—Feeling abnormal—Docetaxel—melanoma	0.00133	0.00337	CcSEcCtD
Nalbuphine—Gastrointestinal pain—Docetaxel—melanoma	0.00132	0.00335	CcSEcCtD
Nalbuphine—Body temperature increased—Docetaxel—melanoma	0.00127	0.00324	CcSEcCtD
Nalbuphine—Abdominal pain—Docetaxel—melanoma	0.00127	0.00324	CcSEcCtD
Nalbuphine—Hypersensitivity—Docetaxel—melanoma	0.00119	0.00302	CcSEcCtD
Nalbuphine—Asthenia—Docetaxel—melanoma	0.00116	0.00294	CcSEcCtD
Nalbuphine—Pruritus—Docetaxel—melanoma	0.00114	0.0029	CcSEcCtD
Nalbuphine—Dizziness—Docetaxel—melanoma	0.00107	0.00271	CcSEcCtD
Nalbuphine—Vomiting—Docetaxel—melanoma	0.00102	0.0026	CcSEcCtD
Nalbuphine—Rash—Docetaxel—melanoma	0.00102	0.00258	CcSEcCtD
Nalbuphine—Dermatitis—Docetaxel—melanoma	0.00101	0.00258	CcSEcCtD
Nalbuphine—Headache—Docetaxel—melanoma	0.00101	0.00256	CcSEcCtD
Nalbuphine—Nausea—Docetaxel—melanoma	0.000957	0.00243	CcSEcCtD
Nalbuphine—OPRK1—Signaling Pathways—GNAQ—melanoma	0.000229	0.000394	CbGpPWpGaD
Nalbuphine—OPRM1—Signaling Pathways—F2R—melanoma	0.000227	0.000392	CbGpPWpGaD
Nalbuphine—OPRD1—Signaling Pathways—SOCS1—melanoma	0.000223	0.000384	CbGpPWpGaD
Nalbuphine—OPRD1—Signaling by GPCR—MAP2K1—melanoma	0.000222	0.000383	CbGpPWpGaD
Nalbuphine—OPRD1—Signaling Pathways—S100B—melanoma	0.000222	0.000383	CbGpPWpGaD
Nalbuphine—OPRD1—Signaling by GPCR—PIK3CD—melanoma	0.000221	0.00038	CbGpPWpGaD
Nalbuphine—OPRM1—Signaling by GPCR—RAC1—melanoma	0.000221	0.00038	CbGpPWpGaD
Nalbuphine—OPRK1—Signaling by GPCR—PIK3CG—melanoma	0.00022	0.000379	CbGpPWpGaD
Nalbuphine—OPRM1—Signaling Pathways—EDNRB—melanoma	0.00022	0.000379	CbGpPWpGaD
Nalbuphine—OPRK1—Signaling Pathways—SYK—melanoma	0.000215	0.00037	CbGpPWpGaD
Nalbuphine—OPRM1—Signaling Pathways—PTK2B—melanoma	0.000214	0.000368	CbGpPWpGaD
Nalbuphine—OPRK1—GPCR downstream signaling—PIK3CD—melanoma	0.000213	0.000367	CbGpPWpGaD
Nalbuphine—OPRD1—Signaling Pathways—ERBB4—melanoma	0.000213	0.000366	CbGpPWpGaD
Nalbuphine—OPRD1—GPCR downstream signaling—PIK3CB—melanoma	0.000212	0.000365	CbGpPWpGaD
Nalbuphine—OPRK1—Signaling Pathways—ITGAV—melanoma	0.000211	0.000364	CbGpPWpGaD
Nalbuphine—OPRK1—Signaling Pathways—AKT3—melanoma	0.000211	0.000364	CbGpPWpGaD
Nalbuphine—OPRK1—Signaling Pathways—NGFR—melanoma	0.000211	0.000364	CbGpPWpGaD
Nalbuphine—OPRD1—Signaling Pathways—CDKN2B—melanoma	0.000211	0.000363	CbGpPWpGaD
Nalbuphine—OPRM1—Signaling Pathways—GAB2—melanoma	0.000208	0.000358	CbGpPWpGaD
Nalbuphine—OPRM1—Signaling Pathways—GNA11—melanoma	0.000208	0.000358	CbGpPWpGaD
Nalbuphine—OPRM1—Signaling Pathways—FLT1—melanoma	0.000207	0.000357	CbGpPWpGaD
Nalbuphine—OPRM1—GPCR downstream signaling—PIK3CG—melanoma	0.000205	0.000353	CbGpPWpGaD
Nalbuphine—OPRD1—Signaling Pathways—CD86—melanoma	0.000204	0.000351	CbGpPWpGaD
Nalbuphine—OPRD1—GPCR downstream signaling—CXCL8—melanoma	0.000204	0.000351	CbGpPWpGaD
Nalbuphine—OPRD1—Signaling Pathways—EDN1—melanoma	0.000202	0.000348	CbGpPWpGaD
Nalbuphine—OPRD1—Signaling Pathways—FGF1—melanoma	0.000198	0.00034	CbGpPWpGaD
Nalbuphine—OPRD1—Signaling Pathways—CSF2—melanoma	0.000198	0.00034	CbGpPWpGaD
Nalbuphine—OPRM1—Signaling Pathways—CXCR4—melanoma	0.000196	0.000337	CbGpPWpGaD
Nalbuphine—OPRM1—Signaling Pathways—FOXO4—melanoma	0.000196	0.000337	CbGpPWpGaD
Nalbuphine—OPRM1—Signaling Pathways—HDAC2—melanoma	0.000196	0.000337	CbGpPWpGaD
Nalbuphine—OPRK1—Signaling Pathways—SOCS1—melanoma	0.000196	0.000337	CbGpPWpGaD
Nalbuphine—OPRK1—Signaling by GPCR—MAP2K1—melanoma	0.000195	0.000336	CbGpPWpGaD
Nalbuphine—OPRK1—Signaling Pathways—S100B—melanoma	0.000195	0.000336	CbGpPWpGaD
Nalbuphine—OPRD1—GPCR downstream signaling—IL2—melanoma	0.000195	0.000335	CbGpPWpGaD
Nalbuphine—OPRK1—Signaling by GPCR—PIK3CD—melanoma	0.000194	0.000334	CbGpPWpGaD
Nalbuphine—OPRD1—Signaling Pathways—E2F1—melanoma	0.000194	0.000333	CbGpPWpGaD
Nalbuphine—OPRM1—Signaling Pathways—GNAQ—melanoma	0.000193	0.000333	CbGpPWpGaD
Nalbuphine—OPRD1—Signaling by GPCR—PIK3CB—melanoma	0.000193	0.000332	CbGpPWpGaD
Nalbuphine—OPRD1—Signaling Pathways—PDGFRA—melanoma	0.000192	0.00033	CbGpPWpGaD
Nalbuphine—OPRD1—Signaling Pathways—ITGB3—melanoma	0.00019	0.000326	CbGpPWpGaD
Nalbuphine—OPRD1—Signaling Pathways—PRKCA—melanoma	0.00019	0.000326	CbGpPWpGaD
Nalbuphine—OPRK1—Signaling Pathways—ERBB4—melanoma	0.000187	0.000321	CbGpPWpGaD
Nalbuphine—OPRM1—Signaling by GPCR—PIK3CG—melanoma	0.000186	0.000321	CbGpPWpGaD
Nalbuphine—OPRK1—GPCR downstream signaling—PIK3CB—melanoma	0.000186	0.00032	CbGpPWpGaD
Nalbuphine—OPRD1—Signaling Pathways—SPP1—melanoma	0.000186	0.00032	CbGpPWpGaD
Nalbuphine—OPRD1—Signaling Pathways—MAP2K2—melanoma	0.000185	0.000319	CbGpPWpGaD
Nalbuphine—OPRD1—Signaling by GPCR—CXCL8—melanoma	0.000185	0.000319	CbGpPWpGaD
Nalbuphine—OPRK1—Signaling Pathways—CDKN2B—melanoma	0.000185	0.000318	CbGpPWpGaD
Nalbuphine—OPRM1—Signaling Pathways—SYK—melanoma	0.000182	0.000313	CbGpPWpGaD
Nalbuphine—OPRM1—GPCR downstream signaling—PIK3CD—melanoma	0.00018	0.00031	CbGpPWpGaD
Nalbuphine—OPRK1—Signaling Pathways—CD86—melanoma	0.000179	0.000308	CbGpPWpGaD
Nalbuphine—OPRK1—GPCR downstream signaling—CXCL8—melanoma	0.000179	0.000308	CbGpPWpGaD
Nalbuphine—OPRM1—Signaling Pathways—NGFR—melanoma	0.000178	0.000307	CbGpPWpGaD
Nalbuphine—OPRM1—Signaling Pathways—AKT3—melanoma	0.000178	0.000307	CbGpPWpGaD
Nalbuphine—OPRM1—Signaling Pathways—ITGAV—melanoma	0.000178	0.000307	CbGpPWpGaD
Nalbuphine—OPRK1—Signaling Pathways—EDN1—melanoma	0.000177	0.000305	CbGpPWpGaD
Nalbuphine—OPRD1—Signaling by GPCR—IL2—melanoma	0.000177	0.000305	CbGpPWpGaD
Nalbuphine—OPRD1—Signaling Pathways—TERT—melanoma	0.000176	0.000303	CbGpPWpGaD
Nalbuphine—OPRD1—Signaling Pathways—RAC1—melanoma	0.000176	0.000303	CbGpPWpGaD
Nalbuphine—OPRK1—Signaling Pathways—CSF2—melanoma	0.000173	0.000299	CbGpPWpGaD
Nalbuphine—OPRK1—Signaling Pathways—FGF1—melanoma	0.000173	0.000299	CbGpPWpGaD
Nalbuphine—OPRK1—GPCR downstream signaling—IL2—melanoma	0.000171	0.000294	CbGpPWpGaD
Nalbuphine—OPRK1—Signaling Pathways—E2F1—melanoma	0.00017	0.000292	CbGpPWpGaD
Nalbuphine—OPRK1—Signaling by GPCR—PIK3CB—melanoma	0.000169	0.000291	CbGpPWpGaD
Nalbuphine—OPRD1—Signaling Pathways—HIF1A—melanoma	0.000169	0.00029	CbGpPWpGaD
Nalbuphine—OPRK1—Signaling Pathways—PDGFRA—melanoma	0.000168	0.000289	CbGpPWpGaD
Nalbuphine—OPRK1—Signaling Pathways—PRKCA—melanoma	0.000166	0.000286	CbGpPWpGaD
Nalbuphine—OPRK1—Signaling Pathways—ITGB3—melanoma	0.000166	0.000286	CbGpPWpGaD
Nalbuphine—OPRM1—Signaling Pathways—SOCS1—melanoma	0.000165	0.000284	CbGpPWpGaD
Nalbuphine—OPRM1—Signaling by GPCR—MAP2K1—melanoma	0.000165	0.000284	CbGpPWpGaD
Nalbuphine—OPRM1—Signaling Pathways—S100B—melanoma	0.000165	0.000284	CbGpPWpGaD
Nalbuphine—OPRM1—Signaling by GPCR—PIK3CD—melanoma	0.000164	0.000282	CbGpPWpGaD
Nalbuphine—OPRK1—Signaling Pathways—SPP1—melanoma	0.000163	0.000281	CbGpPWpGaD
Nalbuphine—OPRK1—Signaling Pathways—MAP2K2—melanoma	0.000163	0.00028	CbGpPWpGaD
Nalbuphine—OPRK1—Signaling by GPCR—CXCL8—melanoma	0.000162	0.000279	CbGpPWpGaD
Nalbuphine—OPRD1—Signaling Pathways—KDR—melanoma	0.000161	0.000278	CbGpPWpGaD
Nalbuphine—OPRM1—Signaling Pathways—ERBB4—melanoma	0.000158	0.000271	CbGpPWpGaD
Nalbuphine—OPRM1—GPCR downstream signaling—PIK3CB—melanoma	0.000157	0.000271	CbGpPWpGaD
Nalbuphine—OPRM1—Signaling Pathways—CDKN2B—melanoma	0.000156	0.000269	CbGpPWpGaD
Nalbuphine—OPRD1—Signaling Pathways—FN1—melanoma	0.000155	0.000267	CbGpPWpGaD
Nalbuphine—OPRK1—Signaling by GPCR—IL2—melanoma	0.000155	0.000267	CbGpPWpGaD
Nalbuphine—OPRK1—Signaling Pathways—TERT—melanoma	0.000155	0.000266	CbGpPWpGaD
Nalbuphine—OPRK1—Signaling Pathways—RAC1—melanoma	0.000154	0.000265	CbGpPWpGaD
Nalbuphine—OPRD1—Signaling Pathways—NOTCH1—melanoma	0.000152	0.000261	CbGpPWpGaD
Nalbuphine—OPRM1—Signaling Pathways—CD86—melanoma	0.000151	0.00026	CbGpPWpGaD
Nalbuphine—OPRM1—GPCR downstream signaling—CXCL8—melanoma	0.000151	0.00026	CbGpPWpGaD
Nalbuphine—OPRM1—Signaling Pathways—EDN1—melanoma	0.00015	0.000258	CbGpPWpGaD
Nalbuphine—OPRD1—Signaling Pathways—CD80—melanoma	0.000149	0.000256	CbGpPWpGaD
Nalbuphine—OPRD1—Signaling Pathways—KIT—melanoma	0.000149	0.000256	CbGpPWpGaD
Nalbuphine—OPRD1—Signaling Pathways—PIK3CG—melanoma	0.000149	0.000256	CbGpPWpGaD
Nalbuphine—OPRD1—Signaling Pathways—APC—melanoma	0.000149	0.000256	CbGpPWpGaD
Nalbuphine—OPRD1—Signaling by GPCR—NRAS—melanoma	0.000149	0.000256	CbGpPWpGaD
Nalbuphine—OPRK1—Signaling Pathways—HIF1A—melanoma	0.000148	0.000254	CbGpPWpGaD
Nalbuphine—OPRD1—Signaling Pathways—EGF—melanoma	0.000147	0.000253	CbGpPWpGaD
Nalbuphine—OPRM1—Signaling Pathways—CSF2—melanoma	0.000147	0.000252	CbGpPWpGaD
Nalbuphine—OPRM1—Signaling Pathways—FGF1—melanoma	0.000147	0.000252	CbGpPWpGaD
Nalbuphine—OPRM1—GPCR downstream signaling—IL2—melanoma	0.000144	0.000249	CbGpPWpGaD
Nalbuphine—OPRM1—Signaling Pathways—E2F1—melanoma	0.000143	0.000247	CbGpPWpGaD
Nalbuphine—OPRM1—Signaling by GPCR—PIK3CB—melanoma	0.000143	0.000246	CbGpPWpGaD
Nalbuphine—OPRD1—Signaling by GPCR—MAPK3—melanoma	0.000142	0.000245	CbGpPWpGaD
Nalbuphine—OPRM1—Signaling Pathways—PDGFRA—melanoma	0.000142	0.000244	CbGpPWpGaD
Nalbuphine—OPRK1—Signaling Pathways—KDR—melanoma	0.000141	0.000243	CbGpPWpGaD
Nalbuphine—OPRM1—Signaling Pathways—ITGB3—melanoma	0.000141	0.000242	CbGpPWpGaD
Nalbuphine—OPRM1—Signaling Pathways—PRKCA—melanoma	0.000141	0.000242	CbGpPWpGaD
Nalbuphine—OPRD1—Signaling Pathways—BRAF—melanoma	0.00014	0.00024	CbGpPWpGaD
Nalbuphine—OPRM1—Signaling Pathways—SPP1—melanoma	0.000138	0.000237	CbGpPWpGaD
Nalbuphine—OPRM1—Signaling Pathways—MAP2K2—melanoma	0.000137	0.000236	CbGpPWpGaD
Nalbuphine—OPRM1—Signaling by GPCR—CXCL8—melanoma	0.000137	0.000236	CbGpPWpGaD
Nalbuphine—OPRK1—Signaling Pathways—FN1—melanoma	0.000136	0.000234	CbGpPWpGaD
Nalbuphine—OPRD1—Signaling Pathways—IGF1—melanoma	0.000136	0.000234	CbGpPWpGaD
Nalbuphine—OPRD1—Signaling by GPCR—MAPK1—melanoma	0.000135	0.000233	CbGpPWpGaD
Nalbuphine—OPRD1—Signaling by GPCR—EGFR—melanoma	0.000135	0.000233	CbGpPWpGaD
Nalbuphine—OPRK1—Signaling Pathways—NOTCH1—melanoma	0.000133	0.000229	CbGpPWpGaD
Nalbuphine—OPRD1—Signaling Pathways—MAP2K1—melanoma	0.000131	0.000226	CbGpPWpGaD
Nalbuphine—OPRM1—Signaling by GPCR—IL2—melanoma	0.000131	0.000226	CbGpPWpGaD
Nalbuphine—OPRM1—Signaling Pathways—TERT—melanoma	0.000131	0.000225	CbGpPWpGaD
Nalbuphine—OPRD1—Signaling Pathways—PIK3CD—melanoma	0.000131	0.000225	CbGpPWpGaD
Nalbuphine—OPRK1—Signaling Pathways—CD80—melanoma	0.00013	0.000225	CbGpPWpGaD
Nalbuphine—OPRM1—Signaling Pathways—RAC1—melanoma	0.00013	0.000224	CbGpPWpGaD
Nalbuphine—OPRK1—Signaling Pathways—KIT—melanoma	0.00013	0.000224	CbGpPWpGaD
Nalbuphine—OPRK1—Signaling Pathways—APC—melanoma	0.00013	0.000224	CbGpPWpGaD
Nalbuphine—OPRK1—Signaling Pathways—PIK3CG—melanoma	0.00013	0.000224	CbGpPWpGaD
Nalbuphine—OPRK1—Signaling by GPCR—NRAS—melanoma	0.00013	0.000224	CbGpPWpGaD
Nalbuphine—OPRD1—GPCR downstream signaling—PIK3CA—melanoma	0.000129	0.000223	CbGpPWpGaD
Nalbuphine—OPRK1—Signaling Pathways—EGF—melanoma	0.000129	0.000222	CbGpPWpGaD
Nalbuphine—OPRD1—Signaling by GPCR—KRAS—melanoma	0.000128	0.00022	CbGpPWpGaD
Nalbuphine—OPRD1—Signaling Pathways—FGF2—melanoma	0.000125	0.000215	CbGpPWpGaD
Nalbuphine—OPRM1—Signaling Pathways—HIF1A—melanoma	0.000125	0.000215	CbGpPWpGaD
Nalbuphine—OPRK1—Signaling by GPCR—MAPK3—melanoma	0.000125	0.000215	CbGpPWpGaD
Nalbuphine—OPRK1—Signaling Pathways—BRAF—melanoma	0.000122	0.000211	CbGpPWpGaD
Nalbuphine—OPRM1—Signaling Pathways—KDR—melanoma	0.000119	0.000206	CbGpPWpGaD
Nalbuphine—OPRK1—Signaling Pathways—IGF1—melanoma	0.000119	0.000205	CbGpPWpGaD
Nalbuphine—OPRK1—Signaling by GPCR—MAPK1—melanoma	0.000119	0.000204	CbGpPWpGaD
Nalbuphine—OPRK1—Signaling by GPCR—EGFR—melanoma	0.000119	0.000204	CbGpPWpGaD
Nalbuphine—OPRD1—Signaling by GPCR—PIK3CA—melanoma	0.000117	0.000202	CbGpPWpGaD
Nalbuphine—OPRD1—Signaling Pathways—MDM2—melanoma	0.000117	0.000201	CbGpPWpGaD
Nalbuphine—OPRD1—Signaling Pathways—ERBB2—melanoma	0.000115	0.000198	CbGpPWpGaD
Nalbuphine—OPRK1—Signaling Pathways—MAP2K1—melanoma	0.000115	0.000198	CbGpPWpGaD
Nalbuphine—OPRM1—Signaling Pathways—FN1—melanoma	0.000115	0.000198	CbGpPWpGaD
Nalbuphine—OPRK1—Signaling Pathways—PIK3CD—melanoma	0.000114	0.000197	CbGpPWpGaD
Nalbuphine—OPRD1—Signaling Pathways—PIK3CB—melanoma	0.000114	0.000196	CbGpPWpGaD
Nalbuphine—OPRK1—GPCR downstream signaling—PIK3CA—melanoma	0.000113	0.000195	CbGpPWpGaD
Nalbuphine—OPRM1—Signaling Pathways—NOTCH1—melanoma	0.000113	0.000194	CbGpPWpGaD
Nalbuphine—OPRK1—Signaling by GPCR—KRAS—melanoma	0.000112	0.000193	CbGpPWpGaD
Nalbuphine—OPRM1—Signaling Pathways—CD80—melanoma	0.00011	0.00019	CbGpPWpGaD
Nalbuphine—OPRM1—Signaling Pathways—PIK3CG—melanoma	0.00011	0.000189	CbGpPWpGaD
Nalbuphine—OPRM1—Signaling Pathways—KIT—melanoma	0.00011	0.000189	CbGpPWpGaD
Nalbuphine—OPRM1—Signaling Pathways—APC—melanoma	0.00011	0.000189	CbGpPWpGaD
Nalbuphine—OPRM1—Signaling by GPCR—NRAS—melanoma	0.00011	0.000189	CbGpPWpGaD
Nalbuphine—OPRK1—Signaling Pathways—FGF2—melanoma	0.00011	0.000189	CbGpPWpGaD
Nalbuphine—OPRD1—Signaling Pathways—CXCL8—melanoma	0.000109	0.000188	CbGpPWpGaD
Nalbuphine—OPRM1—Signaling Pathways—EGF—melanoma	0.000109	0.000187	CbGpPWpGaD
Nalbuphine—OPRD1—Signaling by GPCR—HRAS—melanoma	0.000109	0.000187	CbGpPWpGaD
Nalbuphine—OPRD1—Signaling Pathways—CDKN1B—melanoma	0.000107	0.000184	CbGpPWpGaD
Nalbuphine—OPRD1—GPCR downstream signaling—AKT1—melanoma	0.000106	0.000182	CbGpPWpGaD
Nalbuphine—OPRM1—Signaling by GPCR—MAPK3—melanoma	0.000105	0.000181	CbGpPWpGaD
Nalbuphine—OPRD1—Signaling Pathways—CASP3—melanoma	0.000105	0.00018	CbGpPWpGaD
Nalbuphine—OPRD1—Signaling Pathways—IL2—melanoma	0.000105	0.00018	CbGpPWpGaD
Nalbuphine—OPRD1—Signaling by GPCR—IL6—melanoma	0.000104	0.000179	CbGpPWpGaD
Nalbuphine—OPRM1—Signaling Pathways—BRAF—melanoma	0.000103	0.000178	CbGpPWpGaD
Nalbuphine—OPRK1—Signaling by GPCR—PIK3CA—melanoma	0.000103	0.000177	CbGpPWpGaD
Nalbuphine—OPRK1—Signaling Pathways—MDM2—melanoma	0.000103	0.000177	CbGpPWpGaD
Nalbuphine—OPRD1—Signaling Pathways—CCND1—melanoma	0.000102	0.000175	CbGpPWpGaD
Nalbuphine—OPRK1—Signaling Pathways—ERBB2—melanoma	0.000101	0.000174	CbGpPWpGaD
Nalbuphine—OPRD1—Signaling Pathways—CTNNB1—melanoma	0.000101	0.000174	CbGpPWpGaD
Nalbuphine—OPRM1—Signaling Pathways—IGF1—melanoma	0.000101	0.000173	CbGpPWpGaD
Nalbuphine—OPRM1—Signaling by GPCR—MAPK1—melanoma	0.0001	0.000173	CbGpPWpGaD
Nalbuphine—OPRM1—Signaling by GPCR—EGFR—melanoma	0.0001	0.000173	CbGpPWpGaD
Nalbuphine—OPRK1—Signaling Pathways—PIK3CB—melanoma	9.98e-05	0.000172	CbGpPWpGaD
Nalbuphine—OPRD1—Signaling Pathways—MMP9—melanoma	9.89e-05	0.00017	CbGpPWpGaD
Nalbuphine—OPRD1—Signaling Pathways—CDKN1A—melanoma	9.86e-05	0.00017	CbGpPWpGaD
Nalbuphine—OPRD1—Signaling Pathways—PTEN—melanoma	9.83e-05	0.000169	CbGpPWpGaD
Nalbuphine—OPRD1—Signaling Pathways—NFKB1—melanoma	9.79e-05	0.000168	CbGpPWpGaD
Nalbuphine—OPRM1—Signaling Pathways—MAP2K1—melanoma	9.74e-05	0.000168	CbGpPWpGaD
Nalbuphine—OPRM1—Signaling Pathways—PIK3CD—melanoma	9.68e-05	0.000167	CbGpPWpGaD
Nalbuphine—OPRD1—Signaling by GPCR—AKT1—melanoma	9.59e-05	0.000165	CbGpPWpGaD
Nalbuphine—OPRK1—Signaling Pathways—CXCL8—melanoma	9.59e-05	0.000165	CbGpPWpGaD
Nalbuphine—OPRM1—GPCR downstream signaling—PIK3CA—melanoma	9.58e-05	0.000165	CbGpPWpGaD
Nalbuphine—OPRK1—Signaling by GPCR—HRAS—melanoma	9.53e-05	0.000164	CbGpPWpGaD
Nalbuphine—OPRM1—Signaling by GPCR—KRAS—melanoma	9.47e-05	0.000163	CbGpPWpGaD
Nalbuphine—OPRK1—Signaling Pathways—CDKN1B—melanoma	9.37e-05	0.000161	CbGpPWpGaD
Nalbuphine—OPRM1—Signaling Pathways—FGF2—melanoma	9.26e-05	0.000159	CbGpPWpGaD
Nalbuphine—OPRK1—GPCR downstream signaling—AKT1—melanoma	9.26e-05	0.000159	CbGpPWpGaD
Nalbuphine—OPRK1—Signaling Pathways—CASP3—melanoma	9.18e-05	0.000158	CbGpPWpGaD
Nalbuphine—OPRK1—Signaling Pathways—IL2—melanoma	9.16e-05	0.000158	CbGpPWpGaD
Nalbuphine—OPRK1—Signaling by GPCR—IL6—melanoma	9.12e-05	0.000157	CbGpPWpGaD
Nalbuphine—OPRK1—Signaling Pathways—CCND1—melanoma	8.93e-05	0.000154	CbGpPWpGaD
Nalbuphine—OPRD1—Signaling Pathways—VEGFA—melanoma	8.88e-05	0.000153	CbGpPWpGaD
Nalbuphine—OPRK1—Signaling Pathways—CTNNB1—melanoma	8.85e-05	0.000152	CbGpPWpGaD
Nalbuphine—OPRD1—Signaling Pathways—STAT3—melanoma	8.8e-05	0.000151	CbGpPWpGaD
Nalbuphine—OPRD1—Signaling Pathways—NRAS—melanoma	8.77e-05	0.000151	CbGpPWpGaD
Nalbuphine—OPRM1—Signaling by GPCR—PIK3CA—melanoma	8.7e-05	0.00015	CbGpPWpGaD
Nalbuphine—OPRK1—Signaling Pathways—MMP9—melanoma	8.67e-05	0.000149	CbGpPWpGaD
Nalbuphine—OPRM1—Signaling Pathways—MDM2—melanoma	8.67e-05	0.000149	CbGpPWpGaD
Nalbuphine—OPRK1—Signaling Pathways—CDKN1A—melanoma	8.64e-05	0.000149	CbGpPWpGaD
Nalbuphine—OPRK1—Signaling Pathways—PTEN—melanoma	8.62e-05	0.000148	CbGpPWpGaD
Nalbuphine—OPRK1—Signaling Pathways—NFKB1—melanoma	8.58e-05	0.000148	CbGpPWpGaD
Nalbuphine—OPRM1—Signaling Pathways—ERBB2—melanoma	8.55e-05	0.000147	CbGpPWpGaD
Nalbuphine—OPRM1—Signaling Pathways—PIK3CB—melanoma	8.43e-05	0.000145	CbGpPWpGaD
Nalbuphine—OPRK1—Signaling by GPCR—AKT1—melanoma	8.41e-05	0.000145	CbGpPWpGaD
Nalbuphine—OPRD1—Signaling Pathways—MAPK3—melanoma	8.4e-05	0.000145	CbGpPWpGaD
Nalbuphine—OPRD1—Signaling Pathways—MYC—melanoma	8.17e-05	0.000141	CbGpPWpGaD
Nalbuphine—OPRM1—Signaling Pathways—CXCL8—melanoma	8.1e-05	0.00014	CbGpPWpGaD
Nalbuphine—OPRM1—Signaling by GPCR—HRAS—melanoma	8.05e-05	0.000139	CbGpPWpGaD
Nalbuphine—OPRD1—Signaling Pathways—MAPK1—melanoma	8e-05	0.000138	CbGpPWpGaD
Nalbuphine—OPRD1—Signaling Pathways—EGFR—melanoma	7.99e-05	0.000138	CbGpPWpGaD
Nalbuphine—OPRM1—Signaling Pathways—CDKN1B—melanoma	7.91e-05	0.000136	CbGpPWpGaD
Nalbuphine—OPRM1—GPCR downstream signaling—AKT1—melanoma	7.83e-05	0.000135	CbGpPWpGaD
Nalbuphine—OPRK1—Signaling Pathways—VEGFA—melanoma	7.79e-05	0.000134	CbGpPWpGaD
Nalbuphine—OPRM1—Signaling Pathways—CASP3—melanoma	7.76e-05	0.000134	CbGpPWpGaD
Nalbuphine—OPRM1—Signaling Pathways—IL2—melanoma	7.75e-05	0.000133	CbGpPWpGaD
Nalbuphine—OPRK1—Signaling Pathways—STAT3—melanoma	7.71e-05	0.000133	CbGpPWpGaD
Nalbuphine—OPRM1—Signaling by GPCR—IL6—melanoma	7.71e-05	0.000133	CbGpPWpGaD
Nalbuphine—OPRK1—Signaling Pathways—NRAS—melanoma	7.69e-05	0.000132	CbGpPWpGaD
Nalbuphine—OPRD1—Signaling Pathways—KRAS—melanoma	7.55e-05	0.00013	CbGpPWpGaD
Nalbuphine—OPRM1—Signaling Pathways—CCND1—melanoma	7.55e-05	0.00013	CbGpPWpGaD
Nalbuphine—OPRM1—Signaling Pathways—CTNNB1—melanoma	7.48e-05	0.000129	CbGpPWpGaD
Nalbuphine—OPRK1—Signaling Pathways—MAPK3—melanoma	7.37e-05	0.000127	CbGpPWpGaD
Nalbuphine—OPRM1—Signaling Pathways—MMP9—melanoma	7.33e-05	0.000126	CbGpPWpGaD
Nalbuphine—OPRM1—Signaling Pathways—CDKN1A—melanoma	7.3e-05	0.000126	CbGpPWpGaD
Nalbuphine—OPRM1—Signaling Pathways—PTEN—melanoma	7.29e-05	0.000125	CbGpPWpGaD
Nalbuphine—OPRM1—Signaling Pathways—NFKB1—melanoma	7.25e-05	0.000125	CbGpPWpGaD
Nalbuphine—OPRK1—Signaling Pathways—MYC—melanoma	7.17e-05	0.000123	CbGpPWpGaD
Nalbuphine—OPRM1—Signaling by GPCR—AKT1—melanoma	7.11e-05	0.000122	CbGpPWpGaD
Nalbuphine—OPRK1—Signaling Pathways—MAPK1—melanoma	7.01e-05	0.000121	CbGpPWpGaD
Nalbuphine—OPRK1—Signaling Pathways—EGFR—melanoma	7.01e-05	0.000121	CbGpPWpGaD
Nalbuphine—OPRD1—Signaling Pathways—PIK3CA—melanoma	6.94e-05	0.000119	CbGpPWpGaD
Nalbuphine—OPRD1—Signaling Pathways—TP53—melanoma	6.71e-05	0.000116	CbGpPWpGaD
Nalbuphine—OPRK1—Signaling Pathways—KRAS—melanoma	6.62e-05	0.000114	CbGpPWpGaD
Nalbuphine—OPRM1—Signaling Pathways—VEGFA—melanoma	6.58e-05	0.000113	CbGpPWpGaD
Nalbuphine—OPRM1—Signaling Pathways—STAT3—melanoma	6.52e-05	0.000112	CbGpPWpGaD
Nalbuphine—OPRM1—Signaling Pathways—NRAS—melanoma	6.5e-05	0.000112	CbGpPWpGaD
Nalbuphine—OPRD1—Signaling Pathways—HRAS—melanoma	6.42e-05	0.00011	CbGpPWpGaD
Nalbuphine—OPRM1—Signaling Pathways—MAPK3—melanoma	6.23e-05	0.000107	CbGpPWpGaD
Nalbuphine—OPRD1—Signaling Pathways—IL6—melanoma	6.14e-05	0.000106	CbGpPWpGaD
Nalbuphine—OPRK1—Signaling Pathways—PIK3CA—melanoma	6.08e-05	0.000105	CbGpPWpGaD
Nalbuphine—OPRM1—Signaling Pathways—MYC—melanoma	6.06e-05	0.000104	CbGpPWpGaD
Nalbuphine—OPRM1—Signaling Pathways—MAPK1—melanoma	5.93e-05	0.000102	CbGpPWpGaD
Nalbuphine—OPRM1—Signaling Pathways—EGFR—melanoma	5.92e-05	0.000102	CbGpPWpGaD
Nalbuphine—OPRK1—Signaling Pathways—TP53—melanoma	5.89e-05	0.000101	CbGpPWpGaD
Nalbuphine—OPRD1—Signaling Pathways—AKT1—melanoma	5.67e-05	9.76e-05	CbGpPWpGaD
Nalbuphine—OPRK1—Signaling Pathways—HRAS—melanoma	5.63e-05	9.69e-05	CbGpPWpGaD
Nalbuphine—OPRM1—Signaling Pathways—KRAS—melanoma	5.6e-05	9.63e-05	CbGpPWpGaD
Nalbuphine—OPRK1—Signaling Pathways—IL6—melanoma	5.39e-05	9.27e-05	CbGpPWpGaD
Nalbuphine—OPRM1—Signaling Pathways—PIK3CA—melanoma	5.14e-05	8.85e-05	CbGpPWpGaD
Nalbuphine—OPRM1—Signaling Pathways—TP53—melanoma	4.97e-05	8.56e-05	CbGpPWpGaD
Nalbuphine—OPRK1—Signaling Pathways—AKT1—melanoma	4.97e-05	8.55e-05	CbGpPWpGaD
Nalbuphine—OPRM1—Signaling Pathways—HRAS—melanoma	4.76e-05	8.19e-05	CbGpPWpGaD
Nalbuphine—OPRM1—Signaling Pathways—IL6—melanoma	4.55e-05	7.84e-05	CbGpPWpGaD
Nalbuphine—OPRM1—Signaling Pathways—AKT1—melanoma	4.2e-05	7.23e-05	CbGpPWpGaD
